Paper20031382
Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study.
Virchow JC and 4 others. Respir Med, 2010. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study. Papers, record 20031382. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20031382
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetates | Major topic |
| Adrenergic beta-Agonists | Major topic |
| Anti-Asthmatic Agents | Major topic |
| Asthma | Major topic |
| Quinolines | Major topic |
| Adult | |
| Cyclopropanes | |
| Dose-Response Relationship, Drug | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Quality of Life | |
| Sulfides | |
| Surveys and Questionnaires | |
| Treatment Outcome | |
| Young Adult |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00802789 | Montelukast in Chronic Asthma | Results | Yes |
Source ClinicalTrials.gov
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39953492 | Effect of add-on therapy with leukotriene receptor antagonists and Chungsangboha-tang in patients with asthma: a protocol for a randomized, placebo-controlled, parallel, multicenter trial. | BMC Complement Med Ther | 2025 | https://conductscience.org/library/papers/39953492 | PubMed |
| 34434103 | Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34434103 | PubMed |
| 34403097 | Effects of Medication Use on Small Airway Function and Airway Inflammation in Patients with Clinically Controlled Asthma. | Curr Med Sci | 2021 | https://conductscience.org/library/papers/34403097 | PubMed |
| 33173647 | Role of Montelukast as Monotherapy in Improving Quality of Life of an Asthmatic Patient in Pakistan. | Cureus | 2020 | https://conductscience.org/library/papers/33173647 | PubMed |
| 32727032 | The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians. | J Clin Med | 2020 | https://conductscience.org/library/papers/32727032 | PubMed |
| 31501737 | Role of Montelukast in Improving Quality of Life in Patients with Persistent Asthma. | Cureus | 2019 | https://conductscience.org/library/papers/31501737 | PubMed |
| 31258585 | Effectiveness and Quality of Life with Montelukast in Asthma - A double-blind randomized control trial. | Pak J Med Sci | 2019 | https://conductscience.org/library/papers/31258585 | PubMed |
| 29256220 | Add-on Therapy for Symptomatic Asthma despite Long-Acting Beta-Agonists/Inhaled Corticosteroid. | Tuberc Respir Dis (Seoul) | 2018 | https://conductscience.org/library/papers/29256220 | PubMed |
| 27499820 | Efficacy and Safety of Modified Pranlukast (Prakanon(®)) Compared with Pranlukast (Onon(®)): A Randomized, Open-Label, Crossover Study. | Open Respir Med J | 2016 | https://conductscience.org/library/papers/27499820 | PubMed |
| 27275233 | The Effect of Combined Therapy ICS/LABA and ICS/LABA plus Montelukast in Patients with Uncontrolled Severe Persistent Asthma Based on the Serum IL-13 and FEV1. | Open Access Maced J Med Sci | 2015 | https://conductscience.org/library/papers/27275233 | PubMed |
| 26528362 | Approach to Patients with Severe Asthma: a Consensus Statement from the Respiratory Care Experts' Input Forum (RC-EIF), Iran. | Tanaffos | 2015 | https://conductscience.org/library/papers/26528362 | PubMed |
| 26122504 | Addition of Montelukast to Low-Dose Inhaled Corticosteroid Leads to Fewer Exacerbations in Older Patients Than Medium-Dose Inhaled Corticosteroid Monotherapy. | Allergy Asthma Immunol Res | 2015 | https://conductscience.org/library/papers/26122504 | PubMed |
| 26122501 | More Effective Strategies are Needed for Elderly Asthmatics in Real-World Practice. | Allergy Asthma Immunol Res | 2015 | https://conductscience.org/library/papers/26122501 | PubMed |
| 25948889 | Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations. | Lung India | 2015 | https://conductscience.org/library/papers/25948889 | PubMed |
| 23251741 | Montelukast in asthma: a review of its efficacy and place in therapy. | Ther Adv Chronic Dis | 2011 | https://conductscience.org/library/papers/23251741 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20031382
GET https://conductscience.org/api/papers/v1/20031382/authors